Clinical Trial Update: A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial assesses switching from ropinirole, pramipexole, or cabergoline to the rotigotine transdermal system in idiopathic Parkinson's disease; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• CABERGOLINE (CABERGOLINE)
• Pramipexole (pramipexole)
• Ropinirole (ropinirole)
• Rotigotine Transdermal System (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED